Manus Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 150

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 23

Manus General Information

Description

Developer of a fermentation technology designed to recreate plant processes in microorganisms to produce natural ingredients through fermentation. The company's technology helps in manufacturing complex and bioactive natural products such as flavors, fragrances, food ingredients, bio-pesticides, and pharmaceuticals, enabling businesses to make affordable and sustainable products.

Contact Information

Website
www.manusbio.com
Formerly Known As
Manus Biosynthesis
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 43 Foundry Avenue
  • Suite 230
  • Waltham, MA 02453
  • United States
+1 (706)
Primary Industry
Specialty Chemicals
Other Industries
Agricultural Chemicals
Vertical(s)
AgTech, Climate Tech, Life Sciences
Corporate Office
  • 43 Foundry Avenue
  • Suite 230
  • Waltham, MA 02453
  • United States
+1 (706)

Manus Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Manus Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
20. Secondary Transaction - Private 16-Apr-2025 Completed Generating Revenue
19. Grant 25-Nov-2024 Completed Generating Revenue
18. Later Stage VC 14-May-2024 Completed Generating Revenue
17. Grant 31-Aug-2022 Completed Generating Revenue
16. Debt - General 07-Jun-2022 Completed Generating Revenue
15. Later Stage VC 01-Jan-2022 Completed Generating Revenue
14. Debt - General 20-Aug-2021 Completed Generating Revenue
13. Later Stage VC (Series B) 06-Nov-2020 Completed Generating Revenue
12. Debt - PPP 15-Apr-2020 $874K $22.1M Completed Generating Revenue
11. Later Stage VC (Series A1) 05-Jun-2018 $9.4M $22.1M Completed Generating Revenue
To view Manus’s complete valuation and funding history, request access »

Manus Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B3
Series B2
Series B1
Series A1
Series A
Seed 2 616,765 $0.001000 5% $4.86 $4.86 1x $4.86 10.56%
Seed 1 88,951 $0.001000 10% $4.6 $4.6 1x $4.6 1.52%
To view Manus’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Manus Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a fermentation technology designed to recreate plant processes in microorganisms to produce natural ingredi
Specialty Chemicals
Waltham, MA
150 As of 2026

Loudon, TN

Hayward, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Manus Competitors (18)

One of Manus’s 18 competitors is Primient Covation, a Private Equity-Backed company based in Loudon, TN.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Primient Covation Private Equity-Backed Loudon, TN
Lygos Venture Capital-Backed Hayward, CA
Amyris (Biotechnology) Private Equity-Backed Emeryville, CA
Mane Corporation Le Bar-sur-Loup, France
Biocatalysts Corporate Backed or Acquired Cardiff, United Kingdom
You’re viewing 5 of 18 competitors. Get the full list »

Manus Patents

  • 186

    Total Documents Applications and Grants

  • Total Patents Families

  • 83

    Granted

  • 47

    Pending

  • Expiring in next 12 mo

Manus Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026044195-A1 Cellular engineering for improving microbial biosynthesis Pending 23-Aug-2024
WO-2025235097-A1 Enzymes, cells and methods for making sesquiterpene oils Pending 28-Mar-2024
AU-2024378812-A1 Enzymes, host cells, and methods for producing mogrosides Pending 06-Nov-2023
EP-4805512-A1 Enzymes, host cells, and methods for producing mogrosides Pending 06-Nov-2023
WO-2025101625-A1 Enzymes, host cells, and methods for producing mogrosides Inactive 06-Nov-2023 C12P33/00
To view Manus’s complete patent history, request access »

Manus Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Manus Investors (23)

Investor Name Investor Type Holding Investor Since Participating Rounds
BARDA Government
ND Capital Venture Capital Minority
Angel (individual) Minority
Angel (individual) Minority
Angel (individual) Minority
You’re viewing 5 of 23 investors. Get the full list »

Manus Investments & Acquisitions (4)

Manus’s most recent deal was a Merger/Acquisition with Inscripta.. The deal was made on 15-Apr-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Inscripta. 15-Apr-2025 Merger/Acquisition Biotechnology
WIN Ingredients 17-Nov-2020 Joint Venture Food Products
NutraSweet 03-Jul-2018 Merger/Acquisition Food Products
NutraSweet (Plant in Augusta, Georgia) 29-Jun-2018 Corporate Asset Purchase Buildings and Property
To view Manus’s complete investments and acquisitions history, request access »

Ready to get started?

Request a free trial

Manus Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
NutraSweet Waltham, MA 1965

Manus FAQs

  • When was Manus founded?

    Manus was founded in 2011.

  • Where is Manus headquartered?

    Manus is headquartered in Waltham, MA.

  • What is the size of Manus?

    Manus has 150 total employees.

  • What industry is Manus in?

    Manus’s primary industry is Specialty Chemicals.

  • Is Manus a private or public company?

    Manus is a Private company.

  • What is Manus’s current revenue?

    The current revenue for Manus is .

  • How much funding has Manus raised over time?

    Manus has raised $170M.

  • Who are Manus’s investors?

    BARDA, ND Capital, , , and are 5 of 23 investors who have invested in Manus.

  • Who are Manus’s competitors?

    Primient Covation, Lygos, Amyris (Biotechnology), Mane, and Biocatalysts are some of the 18 competitors of Manus.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process